ReThink CBD Expands Pharmaceutical-Grade Cannabidiol Products Distribution in 10,000 Pharmacies

ReThink CBD is now offering its full-spectrum CBD products nationally through a distribution partnership. The pharmaceutical-grade CBD will be available in over 10,000 independent pharmacies nationwide by the end of the year. It is expected that the distribution channel will reach 15,000 pharmacies by 2020. Their products are intended to be powerful, natural, and beneficial to health and wellness. They are available without prescription and in a variety of forms. Consumers can choose from their array of products to suit their individual needs.

Sublingual tincture oils, gummy drops, gel and powder capsules, shots, sleep support syrups, topical CBD products such as pain relief roll-ons, pain creams, and CBD products for pets are all available. ReThink is also working on a line of CBD skin care products. They are committed to strict testing from harvest to packaging and products are certified for both quality and consistency. Each ReThink CBD product features a QR code on the label to give customers and retailers a Certificate of Analysis for the purchased product. This ensures transparency as well as clarity in the production process.

The company’s vision is recognized globally as a leader in the CBD industry for awareness and quality products. ReThink CBD products can also be found in doctor’s office, chiropractic and wellness centers, hospitals, beauty stores, fitness locations, as well as animal hospitals and veterinarian’s offices.